• 1 January 1981
    • journal article
    • clinical trial
    • Vol. 1  (3) , 175-86
Abstract
This article describes previous studies on a unique protein antitumor antibiotic, neocarzinostatin. Namely, its chemical nature, mode of action at molecular and cellular levels, toxicity and pharmacology, and recent results in clinical trials obtained primarily in Japan have been reviewed briefly.

This publication has 0 references indexed in Scilit: